I want to make a point (to you first) about the corporate governance statement and ASX market announcements with evidence. The point being they seem to have breached it. I'm thinking of asking them in a question did they and if so why and what will they do not to breach it the same way again - change the policy or change the practice?
From this years Annual report -
From the corporate governance statement (last year and this year the same on this section) -
Showing ASX announcements times of the CR investor presentation - which contained DFU info
The reference to "tomorrow" (ie 6 April 2023) comes from this post on HotCopper (number 67142646) - BEFORE not AHEAD of the ASX announcement office getting the presentation announcement.
My point is the corporate governance statement doesn't say - hey maybe well call a trading halt - show the sophs the advanced stuff and no harm no foul - because no one can trade anyway - it says AHEAD.
As a retail investor I have to analyse a report - I think I can do a better job of analysing a report in this very specific field than just about anybody - soph - whatever - if I'm not put in the situation of having to get the same information later than they do.
Related to the corporate governance - this year just past - only 7 board meetings, the previous 9 - in cutting back the number of board meetings did the governance in terms of reporting to the ASX ahead get overlooked?
Another separate point - KPIS - when is partial Met actually just failing to met - relating to another possible question and follow up - Question - was the decision to pursue GvHD phase two trial funding - rather than just pursue DFU and Sculptor which were already running - discretionary on management and the board or was it forced (ie were they contractually obligated to do - WARF -or obligated in some other way ? Discretionary or forced?
If discretionary - how can Kilian justify taking a short term incentive payment for only partially meeting the recruitment requirement - isn't just partial recruitment failing to make use of the funds raised for the purpose of running the trial - which was discretionary - if so why a bonus for under performing? Or have they not underperformed in terms of getting the recruitment done with the funding they had for that?
- Forums
- ASX - By Stock
- Screenshot(s) from Annual Report of 29 Aug 24
CYP
cynata therapeutics limited
Add to My Watchlist
0.00%
!
16.5¢

I want to make a point (to you first) about the corporate...
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
16.5¢ |
Change
0.000(0.00%) |
Mkt cap ! $37.28M |
Open | High | Low | Value | Volume |
16.0¢ | 16.5¢ | 16.0¢ | $10.82K | 65.84K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
2 | 4450 | 16.5¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
17.0¢ | 88474 | 2 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
2 | 4450 | 0.165 |
1 | 30000 | 0.160 |
4 | 66451 | 0.155 |
5 | 136673 | 0.150 |
2 | 45937 | 0.140 |
Price($) | Vol. | No. |
---|---|---|
0.170 | 88474 | 2 |
0.175 | 77450 | 2 |
0.180 | 113494 | 5 |
0.185 | 35990 | 1 |
0.190 | 8868 | 1 |
Last trade - 15.32pm 20/06/2025 (20 minute delay) ? |
Featured News
CYP (ASX) Chart |